Outset Medical, Inc.
OM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.91 | 0.05 | -0.00 | 0.06 |
| FCF Yield | -2.58% | -1.50% | -67.32% | -29.07% |
| EV / EBITDA | -15.61 | -18.08 | -2.91 | -7.32 |
| Quality | ||||
| ROIC | -6.55% | -6.68% | -6.13% | -9.41% |
| Gross Margin | 39.38% | 37.77% | 37.19% | 36.47% |
| Cash Conversion Ratio | 0.35 | 0.26 | 1.00 | 0.64 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.08% | -2.64% | -0.86% | -0.49% |
| Free Cash Flow Growth | -26.69% | 80.16% | -55.99% | 21.14% |
| Safety | ||||
| Net Debt / EBITDA | 2.38 | 2.13 | -1.07 | -4.23 |
| Interest Coverage | -4.45 | -4.85 | -4.61 | -3.75 |
| Efficiency | ||||
| Inventory Turnover | 0.36 | 0.37 | 0.34 | 0.32 |
| Cash Conversion Cycle | 340.74 | 333.80 | 374.56 | 375.74 |